CQDM and Sorintellis Group fund the development of an AI-powered platform to mitigate clinical trial risks

Mila and Sorintellis Announce a Partnership to Optimize Complex Decision-Making Processes in Clinical Drug Development

Mitacs ramps up investment in AI training and helping Canadian businesses adopt AI

Artificial intelligence-powered approach for strategic pharmaceutical portfolio management based on a priori estimation of clinical trial success evolution

Artificial intelligence-powered platform for analyzing the success of clinical trials and interpreting risk factors

Sorintellis, in collaboration with Pfizer, is advancing its ambition to develop an AI-based platform aimed at efficiently mitigating risks in clinical drug development

Interview with Emmanuel Piffo, Sorintellis’ CEO

Development of a proof of concept of an a priori estimation of clinical trial success evolution based on machine learning

Decision-making system for strategic pharmaceutical portfolio management based on artificial intelligence

Sorintellis, IVADO, Polytechnique and Université de Montréal join forces to transform pharmaceutical portfolio management through AI with support from MITACS

Quebec’s Rising Biotech Startups Revolutionizing Canada’s Healthcare Industry

Sorintellis’ team was warmly welcomed at the Computer Research Institute of Montreal (CRIM) to inaugurate a pilot project